contrast media 2-5410-3,
iodixanol,
iodixanol-320,
Visipaque,
Visipaque Unique Softpac,
iodixanol,
92339-11-2,
Visipaque,
Iodixanolum,
Indixanol,
Visipaque 270,
Visipaque 320,
Iodixanolum [Latin],
Lodixanol,
UNII-HW8W27HTXX,
CCRIS 7567,
HW8W27HTXX,
CHEBI:31705,
5,5'-((2-Hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide),
DSSTox_CID_25523,
DSSTox_RID_80929,
DSSTox_GSID_45523,
OptiPrep,
1,3-Benzenedicarboxamide, 5,5'-((2-hydroxy-1,3-propanediyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-,
5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide,
SR-01000872678,
Iodixanol [USAN:BAN:INN],
HSDB 8076,
Iodixanol [USAN:USP:INN:BAN],
Visipaque (TN),
NCGC00016958-01,
2-5410-3A,
CAS-92339-11-2,
Visipaque; Iodixanolum,
AC1L1GKH,
Prestwick0_000848,
Prestwick1_000848,
Prestwick2_000848,
Prestwick3_000848,
EC 618-837-0,
Iodixanol (JAN/USP/INN),
SCHEMBL21546,
BSPBio_000835,
SPBio_002756,
BPBio1_000919,
CHEMBL1200507,
DTXSID2045523,
CTK8G0329,
NBQNWMBBSKPBAY-UHFFFAOYSA-N,
HMS1570J17,
HMS2097J17,
HMS3714J17,
Pharmakon1600-01503835,
BCP11111,
Tox21_110711,
GP8799,
NSC760069,
AKOS015895607,
Tox21_110711_1,
AC-7610,
AN-8826,
CCG-213207,
DB01249,
NSC-760069,
NCGC00179408-01,
NCGC00179408-03,
5-(Acetyl-(3-(acetyl-(3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl)amino)-2- hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; 5,5'-((2-hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide);,
CC-29560,
LS-29753,
2-541O-3A,
AB00513936,
FT-0627254,
FT-0645028,
D01474,
AB00513936_02,
339I112,
A844203,
C-23647,
SR-01000872678-1,
SR-01000872678-2,
BRD-A08660406-001-01-8,
OptiPrep(TM) Density Gradient Medium, used for cell and subcellular organelle isolation,
1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3- propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodo-,
5,5'-(2-hydroxypropane-1,3-diyl)bis(acetylazanediyl)bis(N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide),
5,5'-[(2-hydroxypropane-1,3-diyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide],
5-[[3-[[3,5-bis[2,3-bis(oxidanyl)propylcarbamoyl]-2,4,6-tris(iodanyl)phenyl]-ethanoyl-amino]-2-oxidanyl-propyl]-ethanoyl-amino]-N1,N3-bis[2,3-bis(oxidanyl)propyl]-2,4,6-tris(iodanyl)benzene-1,3-dicarboxamide,
5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodo-anilino]-2-hydroxy-propyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide,
5-[acetyl-[3-[N-acetyl-3,5-bis[(2,3-dihydroxypropylamino)-oxomethyl]-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide,
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide,
Acupaque,
iodixanol-320,
Visipaque Unique Softpac,
D0Y4YG,
contrast media 2-5410-3,
Iodixanol [USAN:INN:BAN],
CID3724,
C35H44I6N6O15,
CS-O-05618,
DU-6807,
C35-H44-I6-N6-O15,
C044834,
1,3-Benzenedicarboxamide, 5,5'-((2-hydroxy-1,3-propanediyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo)-, (16alpha)-,
89797-00-2,